Latest News & Info
Generic ED Meds, Vitaros
The Generic ED Meds, Vitaros, which works within 5 minutes, will be ready in both US and Canada soon
Erectile dysfunction drugs Viagra, Levitra, and Cialis – may have some friendly competition on the horizon in the form of Vitaros, a new medicated cream recently approved in Canada.
There was much talk in 2011 about innovations in the erectile dysfunction field, many of which centred on topical application. But, for all the hype about gels and Viagra condoms, pharmacy shelves still have little to show for it. Even The Generic ED Meds, Vitaros, a top ical cream designed by Apricus Biosciences, which was set to appear in Canada in November, has yet to appear.
The good news is that steps are being taken and there is progress to report. Apricus Biosciences announced in January that the company has licensed the Canadian marketing rights of The Generic ED Meds, Vitaros, to the US-based pharmaceutical giant Abbott Laboratories. Representatives of Apricus say that they expect Abbott to launch The Generic ED Meds, Vitaros, in Canada during 2012. Abbott Laboratories, however, has yet to commit to a time frame.
Earlier this month, Apricus also announced that they had signed an exclusive collaboration agreement with Sandoz, a subsidiary of the multinational pharmaceutical company Novartis International. This collaboration will eventually bring Vitaros to the German public, but for now Apricus have yet to file for marketing authorisation in Europe, although a 2012 European release date has previously been expected. It will, in other words, be some time before Vitaros reaches Germany.
The same is of course true for Italy, where Apricus sold the licensing rights to Bracco SpA as early as in 2010. And should the US Food and Drug Administration approve Vitaros there is even a licensing partner already in the United States: Warner Chilcott. Apricus has long been working to set into place the infrastructure necessary to quickly get The Generic ED Meds, Vitaros, from the laboratory to the public when it is finally approved. Approval is expected since the active ingredient in Vitaros, alprostadil, is already approved for use in penile injections and urethral suppositories, and is currently sold as such under the names Edex, Caverject and MUSE.
The progresses made on getting Vitaros to the public are particularly important because the majority of the impotence therapies available today are based on PDE-5 inhibitors. Vitaros is not, which means that men who feel that regular medications have failed them may still get the results they desire. Additionally, topical application is associated with fewer side-effects than drugs taken orally and studies show that unpleasant side-effects are a major factor in men's choice of drugs. The fact that Vitaros is effective within six minutes is just a bonus.
The difference between Vitaros and Viagra or Cialis?
It’s available in Canada first. Health Canada (the Canadian equivalent of the United States FDA) has officially approved The Generic ED Meds, Vitaros. Marketing plans are currently under way and a Canadian launch is expected in 2011. It may become available in the U.S. Apricus hopes to market the drug to more than 100 additional countries.
They’ve begun the approval process for the United States as well. You rub it on, like salve. The Generic ED Meds, Vitaros, is an on-demand topical cream that is applied directly to the penis before a sexual encounter. It doesn’t contain sidenafil. Rather than the active ingredient in Viagra, Vitaros contains alprostadil, a common vasodilator that is currently distributed as an injection or penile suppository for erectile dysfunction. It has fewer side effects. Since the only U.S. FDA-approved ED meds are in pill form, Vitaros users should expect fewer side effects than those treating their ED with oral medications. The Generic ED Meds, Vitaros, works quickly. Scientists from Apricus say that it produces a viable and sustainable erection within minutes. It’s safer.
Unlike Viagra, Cialis and Levitra, The Generic ED Meds, Vitaros, can be used by patients who are treated with nitrates or alpha blockers for heart problems or diabetes. These patients are discouraged from using the FDA-approved oral ED drugs since those drugs can cause a harmful or fatal drop in blood pressure. Vitaros has been exhaustively tested. The Generic ED Meds, Vitaros, was clinically tested in over 3,300 patients, including some with underlying prostate issues, and was proven to be both safe and effective. It can also be used to heal wounds.
Originally Vitaros was touted as a cream to help heal deep wounds, by encouraging blood supply and enhancing circulation to the wounded tissue. For now, the U.S. will have to wait. The FDA rejected Vitaros in 2008 because of minor concerns over rodent studies. Although Vitaros was submitted for re-assessment in the fourth quarter of 2009, there hasn’t been any new word as of late - but with Canada on board, can the U.S. be far behind?
If you require more information about Generic ED Meds, please click HERE.